- Home
- ATLX vs PRLD Comparison
ATLX vs PRLD Comparison
Compare ATLX & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLX
- PRLD
- Stock Information
- Founded
- ATLX 2011
- PRLD 2016
- Country
- ATLX Brazil
- PRLD United States
- Employees
- ATLX N/A
- PRLD N/A
- Industry
- ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- PRLD Medicinal Chemicals and Botanical Products
- Sector
- ATLX Industrials
- PRLD Health Care
- Exchange
- ATLX Nasdaq
- PRLD Nasdaq
- Market Cap
- ATLX 90.1M
- PRLD 73.7M
- IPO Year
- ATLX N/A
- PRLD 2020
- Fundamental
- Price
- ATLX $4.45
- PRLD $0.90
- Analyst Decision
- ATLX Strong Buy
- PRLD Strong Buy
- Analyst Count
- ATLX 2
- PRLD 2
- Target Price
- ATLX $22.25
- PRLD $4.50
- AVG Volume (30 Days)
- ATLX 146.4K
- PRLD 249.3K
- Earning Date
- ATLX 05-14-2025
- PRLD 05-06-2025
- Dividend Yield
- ATLX N/A
- PRLD N/A
- EPS Growth
- ATLX N/A
- PRLD N/A
- EPS
- ATLX N/A
- PRLD N/A
- Revenue
- ATLX $748,654.00
- PRLD $7,000,000.00
- Revenue This Year
- ATLX $20,462.24
- PRLD N/A
- Revenue Next Year
- ATLX $37.63
- PRLD N/A
- P/E Ratio
- ATLX N/A
- PRLD N/A
- Revenue Growth
- ATLX N/A
- PRLD N/A
- 52 Week Low
- ATLX $3.54
- PRLD $0.61
- 52 Week High
- ATLX $17.72
- PRLD $6.80
- Technical
- Relative Strength Index (RSI)
- ATLX 47.61
- PRLD 60.99
- Support Level
- ATLX $4.03
- PRLD $0.71
- Resistance Level
- ATLX $4.10
- PRLD $0.95
- Average True Range (ATR)
- ATLX 0.31
- PRLD 0.08
- MACD
- ATLX 0.08
- PRLD 0.03
- Stochastic Oscillator
- ATLX 93.81
- PRLD 85.56
About ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.